It might lead to the appropriate utilization of the HDAC7/HDAC2/Nur77 as adjunctive markers for malignancy in pancreatic cancer, and towards the development of new approaches in the design of anti-pancreatic cancer therapy. This evidence concerns the gene HDAC7 and pancreatic neoplasm.